Clinical trial Recruiting at 1 site Phase2; Phase3 Interventional Ages 18 to 70

How genetic differences affect nalbuphine pain relief after abdominal or pelvic surgery

Official title: Exploring the Impact of Genetic Variations on The Clinical Efficacy of Nalbuphine in Postoperative Pain Management

Run by Ziauddin University · NCT06996561 · Data updated 2026-11-12

We will test whether genetic differences change how well nalbuphine relieves pain after abdominal or pelvic surgery in adults.

Quick facts

PhasePhase2; Phase3
Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment263 (estimated)
SponsorZiauddin University
Academic / other
Locations1 site (Karachi, Sindh)
StatusRecruiting
StartedSeptember 1, 2025
Main results expectedJanuary 1, 2027
Study endsJune 30, 2027
Registry record updatedApril 15, 2026
Trial IDNCT06996561 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–70, ASA class 1–3, undergoing open abdomino-pelvic surgeries lasting 2–4 hours who can provide informed consent are the intended participants.

Probably not a fit

Patients with procedures longer than 4 hours, on excluded interacting medications, pregnant or breastfeeding, with opioid allergy or dependency, or receiving epidural/nerve-block analgesia are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional Phase 2/3 study will collect a preoperative blood sample and use next-generation whole exome sequencing to identify genetic variants in adults undergoing open abdomino-pelvic surgeries. All participants receive nalbuphine as part of standard intraoperative and postoperative analgesia, and their pain responses and clinical outcomes will be measured. Investigators will correlate genetic variants with nalbuphine analgesic efficacy to identify markers of opioid sensitivity or resistance within the Pakistani population. The goal is to generate molecular data that could support more personalized and safer opioid use in this setting.

Why it matters

Potential benefit: If successful, the findings could help tailor opioid choice and dosing to patients' genetics, improving pain control and safety after surgery.

How similar studies have gone: Prior clinical work shows nalbuphine, tramadol, and morphine have comparable analgesic effects and opioid pharmacogenetics affects response, but nalbuphine-specific genetic evidence—particularly in Pakistani populations—is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. All adult men or women
2. Age 18 to 70 years
3. ASA criteria 1,2 and 3
4. Abdomino-pelvic surgeries (open hernia repair, appendicectomy, open cholecystectomy, laparotomy, hysterectomy, cystectomy) lasting 2-4 hours

Exclusion Criteria:

1. Surgical procedure duration lasting more than 4 hours
2. Patients taking anti fungal fluconazole, anticoagulant (Warfarin or Clopidogrel) SNRI (Amitryptalline), Rifampicin or Buprenorphine,
3. History of hypersensitivity or allergy to opioids,
4. Pregnant or breastfeeding mothers,
5. History of narcotic dependency, addiction, and withdrawal
6. Patients experiencing any adverse side effects or complications during surgical procedure requiring intensive care admission
7. Refusing to participate in the study
8. Surgical procedures utilizing other modes of intraoperative analgesia e.g epidural analgesia or nerve blocks

Where it's running

  • Ziauddin University
    Karachi, Sindh, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.